Brad H. Vale is a founding general partner at Treo Ventures. He previously led Johnson & Johnson Development Corporation and invested in medical devices, healthtech, and biotech.
At firms with a similar stage, sector and check size.



One email when Brad's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBrad H. Vale is a founding general partner at Treo Ventures. He previously led Johnson & Johnson Development Corporation and invested in medical devices, healthtech, and biotech.
Treo Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder Treo Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
preclinical surgery and product development at Ethicon, J&J; J&J's Corporate Office of Science and Technology; Head at Johnson & Johnson Development Corporation (JJDC); Ethicon; Corporate Office of Science and Technology; investor at Johnson & Johnson.
Last updated 2026-10-15. Is this you? Ask for a correction.